RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,438,816 | -43.2% | 171,084 | -15.2% | 0.00% | -50.0% |
| Q2 2023 | $2,533,427 | -56.8% | 201,706 | -43.4% | 0.00% | -50.0% |
| Q1 2023 | $5,865,165 | +87.6% | 356,112 | +70.2% | 0.00% | +100.0% |
| Q4 2022 | $3,126,046 | -23.1% | 209,240 | +15.1% | 0.00% | -33.3% |
| Q3 2022 | $4,066,000 | +30.4% | 181,778 | -2.4% | 0.00% | +50.0% |
| Q2 2022 | $3,118,000 | +233.1% | 186,158 | +495.5% | 0.00% | +100.0% |
| Q1 2022 | $936,000 | -80.9% | 31,260 | -80.4% | 0.00% | -66.7% |
| Q4 2021 | $4,902,000 | +15.8% | 159,615 | +18.9% | 0.00% | +50.0% |
| Q3 2021 | $4,232,000 | -6.1% | 134,233 | +8.9% | 0.00% | -33.3% |
| Q2 2021 | $4,509,000 | +20.9% | 123,226 | +14.2% | 0.00% | +50.0% |
| Q1 2021 | $3,731,000 | +814.5% | 107,914 | +999.1% | 0.00% | – |
| Q4 2020 | $408,000 | +518.2% | 9,818 | +535.1% | 0.00% | – |
| Q3 2020 | $66,000 | – | 1,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |